Patents by Inventor Ming Ren

Ming Ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260146014
    Abstract: Methods for the production of syringol from biomass are provided. Reactive diluents derived from syringol and their use in 3D printing are also provided.
    Type: Application
    Filed: March 25, 2025
    Publication date: May 28, 2026
    Inventors: Jian Chang, Ming Ren, Daniel Yilin Jiang, Lance Robert Pickens, Xiance Wang, Jessica Kalay Su
  • Publication number: 20250197658
    Abstract: This disclosure provides stable polymerizable resin compositions comprising one or more antioxidant stabilizers to prevent undesired polymerization and/or oxidation of polymerizable components as well as undesired depletion of photoinitiators in the polymerizable resin composition. Such polymerizable resin compositions can be used to produce polymeric materials with properties suitable for use in various mechanical appliances, such as orthodontic appliances.
    Type: Application
    Filed: December 13, 2024
    Publication date: June 19, 2025
    Inventors: Ming Ren, Daniel Yilin Jiang, Jason Safko, Lance Robert Pickens
  • Publication number: 20250102554
    Abstract: Provided are a method, an apparatus, and a system for risk assessment of an insulation state of electrical equipment and a storage medium. The method includes measuring partial discharge data of electrical equipment using multiple types of sensors, and performing clustering of discharge types; establishing, based on a clustering result of each discharge type, a regression model between sensor response amplitude and apparent discharge energy during a discharge development process; calculating, based on the regression model, the accumulated value of apparent discharge energy of current partial discharge of the electrical equipment, and using the accumulated value as an index of risk assessment to assess an insulation state of the electrical equipment.
    Type: Application
    Filed: October 11, 2023
    Publication date: March 27, 2025
    Inventors: Tao ZHANG, Ming REN, Jin MIAO, Haobin GUAN, Kai WANG
  • Publication number: 20250093290
    Abstract: An electrochemical artificial muscle system and an electrochemical artificial muscle testing device are provided. The electrochemical artificial muscle system includes a working electrode including a conductive yarn having a helical structure; a counter electrode containing selected metal elements; an electrolyte including an ionic liquid containing selected ions, the selected ions including the selected metal elements; where the working electrode and the counter electrode are all in contact with the electrolyte. The artificial muscle system based on an aluminum ion battery system has a contractile retention (catch state) characteristic, i.e., artificial muscle yarns contract when a voltage is applied, and after the voltage is removed, the contraction state of the artificial muscle yarn is remained, within almost no any decay within 450 s.
    Type: Application
    Filed: December 9, 2022
    Publication date: March 20, 2025
    Applicant: SUZHOU INSTITUTE OF NANO-TECH AND NANO-BIONICS (SINANO) , CHINESE ACADEMY OF SCIENCES
    Inventors: Jiangtao DI, Ming REN, Panpan XU, Qingwen LI
  • Publication number: 20240261359
    Abstract: The present invention relates to a pharmaceutical composition for use preventing and curing respiratory diseases in winter. The composition comprises burdock seeds, blackberry lily, Platycodon grandiflorus, radix paeoniae rubra, Perilla frutescens, honeysuckle, fructus crataegi, Astragalus membranaceus, Reynoutria japonica, Glycyrrhiza uralensis, and non-essential fermented tea. The present invention also relates to a pharmaceutical preparation use of the pharmaceutical composition. The pharmaceutical composition can be used for nourishing Qi, moistening lungs, clearing throats, relieving sore throats and/or decontaminating, and can be used for preparing a pharmaceutical for treating and/or preventing pharyngitis.
    Type: Application
    Filed: June 24, 2021
    Publication date: August 8, 2024
    Inventors: Boli Zhang, Junhua Zhang, Xinbo Song, Han Zhang, Lin Miao, Kun Zhou, Ming Ren, Erwei Liu, Yuefei Wang, Wenke Zheng, Fengwen Yang
  • Patent number: 11973333
    Abstract: A method for determining phase locking of critical arc light includes: step 1: monitoring and collecting light radiation intensity of an arc inside a switch cabinet in real time, and converting the collected light radiation intensity into an electrical signal; step 2: extracting a power-frequency fundamental wave of the electrical signal, comparing an amplitude of the power-frequency fundamental wave of the electrical signal with a first threshold, and generating a pre-warning signal based on a comparison result of the first threshold; step 3: comparing the amplitude of the power-frequency fundamental wave of the electrical signal with a second threshold voltage, and generating a control signal based on a comparison result of the second threshold voltage and a protection time threshold; and step 4: protecting the switch cabinet under the critical arc light environment based on the pre-warning signal and the control signal.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: April 30, 2024
    Assignee: Wuxi Power Supply Branch of State Grid Jiangsu Electric Power Co., Ltd.
    Inventors: Jin Miao, Ping Chen, Yin Gu, Xi Wu, Jun Qin, Bin Fei, Junfeng Wu, Zhaoyun Leng, Ming Ren
  • Patent number: 11964892
    Abstract: This invention relates to processes for the removal of phosphorous from aqueous waste streams comprising phosphorus-containing compounds produced in the manufacture of glyphosate, in order to meet and typically exceed environmental regulations. More particularly, various embodiments of the present invention relate to the removal of phosphorous-containing compounds utilizing biological treatment system(s), oxidizing agent(s), and/or precipitant(s). The processes of the invention are also applicable to the removal of phosphorous compounds from phosphorous-containing waste streams other than those waste streams resulting from the manufacture of glyphosate.
    Type: Grant
    Filed: February 10, 2022
    Date of Patent: April 23, 2024
    Assignee: Monsanto Technology LLC
    Inventors: Peng Lei, Ming Ren, Anthony E. Vaughn
  • Publication number: 20230187920
    Abstract: A method for determining phase locking of critical arc light includes: step 1: monitoring and collecting light radiation intensity of an arc inside a switch cabinet in real time, and converting the collected light radiation intensity into an electrical signal; step 2: extracting a power-frequency fundamental wave of the electrical signal, comparing an amplitude of the power-frequency fundamental wave of the electrical signal with a first threshold, and generating a pre-warning signal based on a comparison result of the first threshold; step 3: comparing the amplitude of the power-frequency fundamental wave of the electrical signal with a second threshold voltage, and generating a control signal based on a comparison result of the second threshold voltage and a protection time threshold; and step 4: protecting the switch cabinet under the critical arc light environment based on the pre-warning signal and the control signal.
    Type: Application
    Filed: February 6, 2023
    Publication date: June 15, 2023
    Inventors: Jin Miao, Ping Chen, Yin Gu, Xi Wu, Jun Qin, Bin Fei, Junfeng Wu, Zhaoyun Leng, Ming Ren
  • Publication number: 20220162106
    Abstract: This invention relates to processes for the removal of phosphorous from aqueous waste streams comprising phosphorus-containing compounds produced in the manufacture of glyphosate, in order to meet and typically exceed environmental regulations. More particularly, various embodiments of the present invention relate to the removal of phosphorous-containing compounds utilizing biological treatment system(s), oxidizing agent(s), and/or precipitant(s). The processes of the invention are also applicable to the removal of phosphorous compounds from phosphorous-containing waste streams other than those waste streams resulting from the manufacture of glyphosate.
    Type: Application
    Filed: February 10, 2022
    Publication date: May 26, 2022
    Applicant: Monsanto Technology LLC
    Inventors: Peng Lei, Ming Ren, Anthony E. Vaughn
  • Patent number: 11279644
    Abstract: This invention relates to processes for the removal of phosphorous from aqueous waste streams comprising phosphorous-containing compounds produced in the manufacture of glyphosate, in order to meet and typically exceed environmental regulations. More particularly, various embodiments of the present invention relate to the removal of phosphorous-containing compounds utilizing biological treatment system(s), oxidizing agent(s), and/or precipitant(s). The processes of the invention are also applicable to the removal of phosphorous compounds from phosphorous-containing waste streams other than those waste streams resulting from the manufacture of glyphosate.
    Type: Grant
    Filed: June 26, 2018
    Date of Patent: March 22, 2022
    Assignee: Monsanto Technology LLC
    Inventors: Peng Lei, Ming Ren, Anthony E. Vaughn
  • Publication number: 20200131067
    Abstract: This invention relates to processes for the removal of phosphorous from aqueous waste streams comprising phosphorous-containing compounds produced in the manufacture of glyphosate, in order to meet and typically exceed environmental regulations. More particularly, various embodiments of the present invention relate to the removal of phosphorous-containing compounds utilizing biological treatment system(s), oxidizing agent(s), and/or precipitant(s). The processes of the invention are also applicable to the removal of phosphorous compounds from phosphorous-containing waste streams other than those waste streams resulting from the manufacture of glyphosate.
    Type: Application
    Filed: June 26, 2018
    Publication date: April 30, 2020
    Applicant: Monsanto Technology LLC
    Inventors: Peng Lei, Ming Ren, Anthony E. Vaughn
  • Publication number: 20160146616
    Abstract: A method and apparatus of vehicle positioning uses map matching as feedback for an integrated navigation system where a map and navigation system is coupled with an inertial navigation system (INS) using low-precision vehicle sensors when the vehicle passes through a tunnel or other area suffering from GPS signal loss. The method and apparatus operates to detect whether the vehicle has reached an entry point of a tunnel, and if so, immediately starts a map matching operation to match the current vehicle position with a road link of the tunnel. The current position determined by the map matching operation is feedbacked to an integration Kalman filter thereby correcting errors caused by the vehicle sensors. The method and apparatus resumes the normal navigation operation including GPS navigation as soon as it detects that the vehicle is out of the tunnel.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 26, 2016
    Inventor: Ming Ren
  • Patent number: 9211310
    Abstract: The present invention relates to a use of Chinese medicine composition in preparation of medicine for secondary prevention of myocardial infarction. Said Chinese medicine composition is prepared from a formula comprising the crude drugs by the following weight percentages: Radix Astragali 22.2%˜66.8%, Radix Salviae Miltiorrhizae 11.6%˜33.4%, Radix Notoginseng 2.5%˜13.5%, and Lignum Dalbergiae Odoriferae 14.5%˜44.3%.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: December 15, 2015
    Assignee: TASLY PHARMACEUTICAL GROUP CO., LTD
    Inventors: Boli Zhang, Hongcai Shang, Chen Yao, Baoyan Liu, Weiliang Weng, Yuxia Zhao, Guohua Dai, Xiumei Gao, Ming Ren, Junhua Zhang, Hongbo Cao, Jingyuan Mao, Xuejun Hu, Zhisheng Jin, Junping Zhang, Yiyu Cheng, Xijun Yan, Jiazhen Qu, Hui Wang, Hongjuan Xu, Wenke Zheng
  • Publication number: 20130209590
    Abstract: The present invention relates to a use of Chinese medicine composition in preparation of medicine for secondary prevention of myocardial infarction. Said Chinese medicine composition is prepared from a formula comprising the crude drugs by the following weight percentages: Radix Astragali 22.2%˜66.8%, Radix Salviae Miltiorrhizae 11.6%˜33.4%, Radix Notoginseng 2.5%˜13.5%, and Lignum Dalbergiae Odoriferae 14.5%˜44.3%.
    Type: Application
    Filed: June 28, 2011
    Publication date: August 15, 2013
    Applicant: TASLY PHARMACEUTICAL GROUP CO., LTD.
    Inventors: Boli Zhang, Hongcai Shang, Chen Yao, Baoyan Liu, Weiliang Weng, Yuxia Zhao, Guohua Dai, Xiumei Gao, Ming Ren, Junhua Zhang, Hongbo Cao, Jingyuan Mao, Xuejun Hu, Zhisheng Jin, Junping Zhang, Yiyu Cheng, Xijun Yan, Jiazhen Qu, Hui Wang, Hongjuan Xu, Wenke Zheng
  • Patent number: D965658
    Type: Grant
    Filed: November 14, 2021
    Date of Patent: October 4, 2022
    Inventor: Ming Ren